Parsaik AK, Mascarenhas SS, Hashmi A, Prokop LJ, Vineeth J, Okusaga O, et al. Role of Botulinum Toxin in Depression. J Psychiatr Pract [Internet]. 2016 Mar [citado 21 Ene 2020];22(2):99-110. Disponible en: https://journals.lww.com/practicalpsychiatry/fulltext/2016/03000/Role_of_Botulinum_Toxin_in_Depression.4.aspx

França K, Lotti T. Botulinum toxin for the treatment of depression. Dermatol Ther [Internet]. 2017 [citado 21 Ene 2020];30(2):e12422. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/dth.12422

Stearns TP, Shad M, Guzman GC. Glabellar Botulinum Toxin Injections in Major Depressive Disorder: A Critical Review. Prim Care Companion CNS Disord [Internet]. 2018 Oct [citado 21 Ene 2020];20(5):18r02298. Disponible en: https://ohsu.pure.elsevier.com/en/publications/glabellar-botulinum-toxin-injections-in-major-depressive-disorder. https://doi.org/10.4088/PCC.18r02298

Finzi E, Kels L, Axelowitz J, Shaver B, Eberlein C, Krueger TH, et al. Botulinum toxin therapy of bipolar depression: A case series. J Psychiatr Res [Internet]. 2018 Sep [citado 21 Ene 2020];104:55-57. Disponible en: http://www.botoxfordepression.com/wp-content/uploads/2018/08/BotoxBipolarDepressionJPR.pdf

Kruger TH, Wollmer MA. Depression—an emerging indication for botulinum toxin treatment. Toxicon [Internet]. 2015 Dec [citado 21 Ene 2020];107(Pt A):154-7. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0041010115300945

Chugh S, Chhabria A, Jung S, Kruger THC, Wollmer MA. Botulinum Toxin as a Treatment for Depression in a Real-world Setting. J Psychiatr Pract [Internet]. 2018 Jan [citado 21 Ene 2020];24(1):15-20. Disponible en: https://journals.lww.com/practicalpsychiatry/Fulltext/2018/01000/Botulinum_Toxin_as_a_Treatment_for_Depression_in_a.3.aspx

Magid M, Keeling BH, Reichenberg JS. Neurotoxins: expanding uses of neuromodulators in medicine—major depressive disorder. Plast Reconstr Surg [Internet]. 2015 Nov [citado 21 Ene 2020];136(5 Suppl):111S-119S. Disponible en: https://journals.lww.com/plasreconsurg/Abstract/2015/11001/Neurotoxins__Expanding_Uses_of_Neuromodulators_in.20.aspx

Zamanian A, Ghanbari Jolfaei A, Mehran G, Azizian Z. Efficacy of botox versus placebo for treatment of patients with major depression. Iran J Public Health [Internet]. 2017 Jul [citado 21 Ene 2020];46(7):982-984. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563881/

Brin MF, Durgam S, Lum A, James L, Liu J, Thase ME, et al. Onabotulinum toxin A for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females. Int Clin Psychopharmacol [Internet]. 2020 Jan [citado 21 Ene 2020];35(1):19-28. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903360/